ICAD Stock

ICAD EV/EBITDA

Delisted·Jul 16, 2025

The EV/EBITDA (Enterprise Value to EBITDA) of ICAD (ICAD) as of Aug 16, 2026 is -14.79. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -11.38 — a change of 29.98% (lower).

EV/EBITDA

-14.79

YoY

29.98%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of ICAD is 2026 -14.79 . EV/EBITDA (Enterprise Value to EBITDA) of ICAD was 2025 -11.38 . It decreases by 29.98% lower compared to the previous year.
Access this data via the Eulerpool API

ICAD Stock analysis

What does ICAD do? ICAD Inc is a leading company in medical imaging and automated image processing. It was founded in 1984 and is headquartered in Nashua, New Hampshire, USA. ICAD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICAD stock

EV/EBITDA (Enterprise Value to EBITDA) of ICAD is -14.79 in 2026.

EV/EBITDA (Enterprise Value to EBITDA) of ICAD changed from -11.38 to -14.79, representing a 29.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) ICAD since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s ICAD with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — ICAD

All Key Metrics — ICAD